Intranasal midazolam in patients with fitz

Emergency Medicine Journal

Volumn 22, Issue 6, 2005, Pages 436-437

  Smith, Martin ^a   Carley, Simon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; MIDAZOLAM; HYPNOTIC SEDATIVE AGENT;

ABSTRACT REPORT; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVIDENCE BASED MEDICINE; HUMAN; MEDLINE; METHODOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; INTRANASAL DRUG ADMINISTRATION; REVIEW; SEIZURE;

ADMINISTRATION, INTRANASAL; HUMANS; HYPNOTICS AND SEDATIVES; MIDAZOLAM; SEIZURES; TREATMENT OUTCOME;

EID: 20344401568     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2005.025726     Document Type: Short Survey

References (4)

1. O'Regan ME, Brown JK, Clarke M. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures? Dev Med Child Neurol 1996;38:1037-45.
2. Kendall JL, Reynolds M, Goldberg R. Intranasal midazolam in patients with status epilepticus. Ann Emerg Med 1997;29:415-17.
3. Scheepers M, Scheepers B, Clough P. Midazolam via the intranasal route: an effective rescue medication for severe epilepsy in adults with learning disability. Seizure 1998;7:509-12.
4. Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav 2004;5:253-5.